A20 Haploinsufficiency in East Asia

Area of Science:

• Immunology
• Genetics
• Rheumatology

Background:

• A20, encoded by TNFAIP3, negatively regulates TNF-NF-κB signaling.
• A20 haploinsufficiency (HA20) can mimic Behçet's disease (BD) with autoinflammatory, autoimmune, and immunodeficiency symptoms.
• HA20 phenotypes vary widely, influenced by genetic background and environment.

Purpose of the Study:

• To review and compare HA20 patient characteristics in East Asia with those in other regions (USA, Europe).
• To highlight regional differences in HA20 presentation and management.

Main Methods:

• Literature review and comparative analysis of published HA20 patient data.
• Focus on clinical features, disease complications, and treatment strategies across different geographic regions.

Main Results:

• East Asian HA20 patients more frequently experienced recurrent fevers but less often presented with typical BD symptoms like skin/genital ulcers.
• Lower rates of autoimmune disease complications and autoantibody detection were observed in East Asian patients.
• Treatment varied, with anti-TNF-α agents common in East Asia, while anti-IL-1 agents and JAK inhibitors were used elsewhere.

Conclusions:

• Significant regional variations exist in HA20 clinical presentation and associated conditions.
• Further research is needed to understand HA20 pathophysiology and optimize region-specific treatment strategies.